UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Liver-directed surgery of neuroendocrine metastases: What is the optimal strategy?

Surgery, 2016-01, Vol.159 (1), p.320-335

2016

Volltextzugriff (PDF)

Daily Oral Everolimus Activity in Patients With Metastatic Pancreatic Neuroendocrine Tumors After Failure of Cytotoxic Chemotherapy: A Phase II Trial

Journal of clinical oncology, 2010-01, Vol.28 (1), p.69-76

2010

Volltextzugriff (PDF)

Chemokine Receptor CXCR4 Radioligand Targeted Therapy Using 177Lutetium-pentixather for Pulmonary Neuroendocrine Cancers

Radiation research, 2023-11, Vol.201 (1)

2023

Volltextzugriff (PDF)

Recommended Guidelines for the Treatment of Cancer Treatment-Induced Diarrhea

Journal of clinical oncology, 2004-07, Vol.22 (14), p.2918-2926

2004

Volltextzugriff (PDF)

Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors

The New England journal of medicine, 2017-01, Vol.376 (2), p.125-135

2017

Volltextzugriff (PDF)

Overview of Results of Peptide Receptor Radionuclide Therapy with 3 Radiolabeled Somatostatin Analogs

The Journal of nuclear medicine (1978), 2005-01, Vol.46 (1 suppl), p.62S

2005

Volltextzugriff (PDF)

RABL6A promotes G1-S phase progression and pancreatic neuroendocrine tumor cell proliferation in an Rb1-dependent manner

Cancer research (Chicago, Ill.), 2014-11, Vol.74 (22), p.6661-6670

2014

Volltextzugriff (PDF)

Effective cytoreduction can be achieved in patients with numerous neuroendocrine tumor liver metastases (NETLMs)

Surgery, 2019-01, Vol.165 (1), p.166-175

2019

Volltextzugriff (PDF)

Identification of primary tumors in patients presenting with metastatic gastroenteropancreatic neuroendocrine tumors

Surgery, 2017-01, Vol.161 (1), p.272-279

2017

Volltextzugriff (PDF)

Gene Expression Signatures Identify Novel Therapeutics for Metastatic Pancreatic Neuroendocrine Tumors

Clinical cancer research, 2020-04, Vol.26 (8), p.2011-2021

2020

Volltextzugriff (PDF)

Gastric inhibitory polypeptide receptor (GIPR) is a promising target for imaging and therapy in neuroendocrine tumors

Surgery, 2013-12, Vol.154 (6), p.1206-1214

2013

Volltextzugriff (PDF)

Medical management of metastatic medullary thyroid cancer

Cancer, 2014-11, Vol.120 (21), p.3287-3301

2014

Volltextzugriff (PDF)

A practical method to determine the site of unknown primary in metastatic neuroendocrine tumors

Surgery, 2014-12, Vol.156 (6), p.1359-1366

2014

Volltextzugriff (PDF)

Gene expression in neuroendocrine tumor liver metastases accurately distinguishes between pancreas and small bowel primary tumors

Journal of the American College of Surgeons, 2013-09, Vol.217 (3), p.S129-S129

2013

Volltextzugriff (PDF)

Severe metabolic bone disease as a long-term complication of obesity surgery

Obesity surgery, 2002-10, Vol.12 (5), p.685-692

2002

Volltextzugriff (PDF)

Somatic Alterations of CDKN1B Are Associated with Small Bowel Neuroendocrine Tumors

Journal of the American College of Surgeons, 2014-09, Vol.219 (3), p.S126-S127

2014

Volltextzugriff (PDF)

Addition of 131 I-MIBG to PRRT ( 90 Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors

Journal of Nuclear Medicine, 2021-09, Vol.62 (9), p.1274-1277

2021

Volltextzugriff (PDF)

Changes in gene expression in small bowel neuroendocrine tumors associated with progression to metastases

Surgery, 2018-01, Vol.163 (1), p.232-239

2018

Volltextzugriff (PDF)

Addition of 131I-MIBG to PRRT (90Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors

The Journal of nuclear medicine (1978), 2021-09, Vol.62 (9), p.1274-1277

2021

Volltextzugriff (PDF)

90Y-Edotreotide for Metastatic Carcinoid Refractory to Octreotide

Journal of clinical oncology, 2010-04, Vol.28 (10), p.1652-1659

2010

Volltextzugriff (PDF)

Differentiation of small bowel and pancreatic neuroendocrine tumors by gene-expression profiling

Surgery, 2012-12, Vol.152 (6), p.998-1007

2012

Volltextzugriff (PDF)

Motor Neuron and Pancreas Homeobox 1 Mutations in Patients with Familial Neuroendocrine Tumors

Journal of the American College of Surgeons, 2018-10, Vol.227 (4), p.S85-S86

2018

Volltextzugriff (PDF)

90 Y-DOTATOC Dosimetry-Based Personalized Peptide Receptor Radionuclide Therapy

Journal of Nuclear Medicine, 2018-11, Vol.59 (11), p.1692-1698

2018

Volltextzugriff (PDF)

90Y-DOTATOC Dosimetry-Based Personalized Peptide Receptor Radionuclide Therapy

The Journal of nuclear medicine (1978), 2018-11, Vol.59 (11), p.1692-1698

2018

Volltextzugriff (PDF)

Distal Predilection of Small Bowel Neuroendocrine Tumors

Journal of the American College of Surgeons, 2016-10, Vol.223 (4), p.S46-S46

2016

Volltextzugriff (PDF)

1 – 25 von 144

Suche als RSS-Feed

Aktive Filter

KollektionSingle Journals

SpracheEnglisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(136)
Mit Volltextzugriff
(107)

Publikationsform

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Liver-directed surgery of neuroendocrine metastases: What is the optimal strategy?

Daily Oral Everolimus Activity in Patients With Metastatic Pancreatic Neuroendocrine Tumors After Failure of Cytotoxic Chemotherapy: A Phase II Trial

Chemokine Receptor CXCR4 Radioligand Targeted Therapy Using 177Lutetium-pentixather for Pulmonary Neuroendocrine Cancers

Recommended Guidelines for the Treatment of Cancer Treatment-Induced Diarrhea

Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors

Overview of Results of Peptide Receptor Radionuclide Therapy with 3 Radiolabeled Somatostatin Analogs

RABL6A promotes G1-S phase progression and pancreatic neuroendocrine tumor cell proliferation in an Rb1-dependent manner

Effective cytoreduction can be achieved in patients with numerous neuroendocrine tumor liver metastases (NETLMs)

Identification of primary tumors in patients presenting with metastatic gastroenteropancreatic neuroendocrine tumors

Gene Expression Signatures Identify Novel Therapeutics for Metastatic Pancreatic Neuroendocrine Tumors

Gastric inhibitory polypeptide receptor (GIPR) is a promising target for imaging and therapy in neuroendocrine tumors

Medical management of metastatic medullary thyroid cancer

A practical method to determine the site of unknown primary in metastatic neuroendocrine tumors

Gene expression in neuroendocrine tumor liver metastases accurately distinguishes between pancreas and small bowel primary tumors

Severe metabolic bone disease as a long-term complication of obesity surgery

Somatic Alterations of CDKN1B Are Associated with Small Bowel Neuroendocrine Tumors

Addition of 131 I-MIBG to PRRT ( 90 Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors

Changes in gene expression in small bowel neuroendocrine tumors associated with progression to metastases

Addition of 131I-MIBG to PRRT (90Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors

90Y-Edotreotide for Metastatic Carcinoid Refractory to Octreotide

Differentiation of small bowel and pancreatic neuroendocrine tumors by gene-expression profiling

Motor Neuron and Pancreas Homeobox 1 Mutations in Patients with Familial Neuroendocrine Tumors

90 Y-DOTATOC Dosimetry-Based Personalized Peptide Receptor Radionuclide Therapy

90Y-DOTATOC Dosimetry-Based Personalized Peptide Receptor Radionuclide Therapy

Distal Predilection of Small Bowel Neuroendocrine Tumors

Aktive Filter

Suchergebnisse filtern